SAMBALPUR: A team from the State Archaeology wing on Wednesday conducted a detailed survey of the historic Maa Samaleswari temple to assess conservation and restoration needs, with a focus on seepage, ...

As the calendar turned from April to May, a big change came to the FDA. Vinay Prasad, M.D., director of the Center for Biologics Evaluation and Research, officially departed from the agency for the ...

Prasad Kalyanaraman, VP of AWS Infrastructure Services, has been named to Amazon’s senior leadership team. (Amazon Photo) Amazon added a new member to its senior leadership team Wednesday, naming AWS ...

The revolving door at the Food and Drug Administration has pushed out another top official: Vinay Prasad, the controversial head of the agency’s vaccine and gene therapy arm, will depart in April.

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he's departed after controversial decisions ...

The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the end of April. FDA commissioner Dr. Marty Makary posted ...

Food and Drug Administration (FDA) Commissioner Marty Makary on Friday announced that the agency’s top regulator Vinay Prasad will depart next month. “A year ago, Dr. Prasad came to the FDA to ...

The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said Friday. Prasad was appointed last year as director of the FDA’s Center ...

Dr. Vinay Prasad drew criticism for overriding career scientists and rejecting drugs by companies seeking agency approval. By Christina Jewett Dr. Vinay Prasad, a polarizing figure at the Food and ...

Lizzy led STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

After a tumultuous tenure marked by recent clashes with the biopharma industry, Vinay Prasad, M.D., will be departing his post as the FDA’s top regulator of vaccines and cell and gene therapies at the ...